ADIPOQ and Insulin resistance: The anti-inflammatory effects and improvement of insulin resistance in the treatment with Sitagliptin and Berberine-induced synergistic pathways may modulate hepatic transaminases (ALT AST), increase adiponectin, and reduce TNFα.